The Italian pharmaceutical antitrust (r)evolution and its most recent example: the Aspen case, European Competiton Journal, issue 1 2017
Condividi
The Italian pharmaceutical antitrust (r)evolution and its most recent example: the Aspen case, European Competiton Journal, issue 1 2017